Nikolai Tankovich, M.D., Ph.D., FASLMS (Chair)
Executive Chairman & Director, Stemedica International SA
President & Chief Medical Officer, Stemedica Cell Technologies Inc.
Dr. Nikolai Tankovich is Stemedica International’s chairman of the board. Dr. Tankovich is a recognized innovator, licensor, researcher and educator of laser applications in medicine, cancer vaccines, stem-cell therapies and other medical-related disciplines. A founder and director of several corporations, Dr. Tankovich is respected worldwide for his innovative work; he has published more than 60 articles and holds more than 50 U.S. and foreign patents issued and pending. His inventions include devices for laser hair removal and laser skin peeling, non-ablative wrinkle removal and laser lancet (all three licensed and FDA approved). He was the first in the world to propose, invent, develop, patent, build and use a 1.54 micron Er:Glass laser for Fraxel and medical applications. Among his numerous awards and honors is the Gold Kurchatov Medal for the Atomic Science Application in Medicine and Biology awarded by the Atomic Energy Agency in 1998. On the 8th of November, 2011, the Trustees of the Centre for Science and Society appointed Dr. Tankovich as a Legate of the Centre.
Dr. Tankovich also has worked on laser diagnosis and surgery of malignant and background uterine cervix diseases and the intraoperation laser diagnosis of early forms of breast cancer. He earned his Ph.D. in BioPhysics from Lomonosov Moscow University, his M.D. from Semashco Medical University in Moscow and his M.S. in Plasma Physics from Moscow University. He practiced as an oncologist, focusing on new ways to deliver cancer drugs into organs.